Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know - 2Earth's newfound 'episodic-squishy lid' may guide our search for habitable worlds
- 3Opening Your True capacity: 12 Techniques for Personal growth
- 4Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- 5Progress Over Perfection: Lessons From Garment Factories Fighting Heat Stress
- Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
- Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- NASA releases new ‘Earthset’ and eclipse images taken during historic flyby of the moon
- Home Plan Tips for Seniors
- 7 Espresso Machines for Home Baristas
- Robert Irwin on winning 'Dancing With the Stars' 10 years after sister Bindi: 'This was everything I dreamed it would be and so much more'
- 10 Activities to Lift Your Consume and Bust Your Stomach
- The Development of Shipping: Controlling Towards a More Associated Future
- African Forests Have Become a Source of Carbon Emissions
